Astonishingly, the combination of Pin1 inhibitors and immunochemotherapy achieved over 85% tumor eradication after 1 year even with only 4 months of the treatment, compared with 0% in the immunochemotherapy group alone (Koikawa et al., 2021). This evidence concerns the gene PIN1 and neoplasm.